Medtronic (MDT) is a publicly traded Healthcare sector company. As of July 5, 2026, MDT trades at $83.19 with a market cap of $106.49B and a P/E ratio of 22.18. MDT moved +5.05% today. Year to date, MDT is -13.94%; over the trailing twelve months it is -5.77%. Its 52-week range spans $73.31 to $106.33. Analyst consensus is buy with an average price target of $97.90. Rallies surfaces MDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Johnson & Johnson Raises 2026 Revenue Growth Forecast to 6.1%: Johnson & Johnson raised its 2026 revenue growth forecast to 6.1% on April 14 and outlined a path to double-digit growth by 2030, backed by its largest ever pipeline. Since the update, shares have returned -0.2% while implied volatility in options has climbed to the 85th percentile.
| Metric | Value |
|---|---|
| Price | $83.19 |
| Market Cap | $106.49B |
| P/E Ratio | 22.18 |
| EPS | $3.75 |
| Dividend Yield | 0.72% |
| 52-Week High | $106.33 |
| 52-Week Low | $73.31 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $36.36B |
| Net Income | $4.84B |
| Gross Margin | 65.02% |
21 analysts cover MDT: 0 strong buy, 13 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $97.90.